Genprex, Inc. (GNPX)
2.04
-0.16
(-7.27%)
USD |
NASDAQ |
Feb 12, 16:00
2.10
+0.06
(+2.94%)
After-Hours: 06:16
Genprex Cash from Investing (Quarterly) : 0.00 for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Arvinas, Inc. | 63.50M |
| Olema Pharmaceuticals, Inc. | 17.27M |
| ACADIA Pharmaceuticals, Inc. | -79.35M |
| Alnylam Pharmaceuticals, Inc. | 501.11M |
| Savara, Inc. | 21.47M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.187M |
| Cash from Financing (Quarterly) | 2.944M |
| Free Cash Flow | -15.08M |
| Free Cash Flow Per Share (Quarterly) | -4.191 |
| Free Cash Flow to Equity (Quarterly) | -3.187M |
| Free Cash Flow to Firm (Quarterly) | -3.187M |
| Free Cash Flow Yield | -176.1% |